Basiliximab induction alone vs a dual ATG–basiliximab approach in first live-donor non-sensitized kidney transplant recipients with low HLA matching
In non-sensitized first live-donor KTRs with low HLA matching, a dual ATG-basiliximab induction approach significantly reduced early ACR without compromising safety.
Authors
- Niv Pencovich (ORCID: https://orcid.org/0000-0002-0049-0295)
- Shmuel Levinger
- Tammy Hod (ORCID: https://orcid.org/0000-0001-9072-7606)
- Ido Nachmani
- Eytan Mor (ORCID: https://orcid.org/0000-0001-8698-0860)
- Yana Davidov (ORCID: https://orcid.org/0000-0002-6524-1644)
- Enosh M. Askenasy
- Ronen Ghinea
- Maya Siman‐Tov (ORCID: https://orcid.org/0000-0002-6472-7159)
Institutions
- Tel Aviv University (IL)
- Sheba Medical Center (IL)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1093/ckj/sfae236
- Citations
- 2
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.02